Article
Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and Treatment.
Hematology/oncology clinics of North America - 1 Apr 2020
Winer Eric S
Abstract excerpt
Secondary acute myeloid leukemia (sAML) is a complex diagnosis that includes AML caused by either an antecedent hematologic disease (AML-AHD) or from previous treatment with chemotherapy or radiation. This disease carries a poor prognosis and is historically chemorefractory; additionally, often patients are ineligible for standard chemotherapy because of advanced age and other comorbidities. The advances of...
Topics
- Biomarkers, Tumor
- Combined Modality Therapy
- Disease Management
- Disease Susceptibility
- Genetic Predisposition to Disease
- Humans
- Incidence
- Leukemia, Myeloid, Acute
- Prognosis
- Treatment Outcome